The pharmacological management of drug-induced rheumatic disorders
Authors:
- 1 October 2001
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 2 (10) , 1623-1631
Abstract
Many drugs can induce adverse effects such as rheumatoid disorders, which we need to be aware of in order to best detect and manage them. New drugs are constantly entering the marketplace and can cause an increasing number of disorders. Through this article, we review the prevention and pharmacological management of drug-induced rheumatic disorders. These include articular and peri-articular manifestations induced by fluoroquinolones, retinoids, cyclosporin, drug-induced disorders of bone metabolism such as corticosteroid-induced osteoporosis and drug-induced osteomalacia, and multisystemic manifestations including drug-induced lupus and arthritis induced by vaccinations and cytokines.Keywords
This publication has 36 references indexed in Scilit:
- Acute arthritis after intra-articular hyaluronate injection: onset of effusions without crystalAnnals of the Rheumatic Diseases, 2001
- InfliximabDrugs, 2000
- Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.Journal of Clinical Investigation, 1998
- The safety of etretinate as long-term therapy for psoriasis: Results of the Etretinate Follow-up StudyJournal of the American Academy of Dermatology, 1995
- Safety of ciprofloxacin therapy in children: magnetic resonance images, body fluid levels of fluoride and linear growthActa Paediatrica, 1995
- Drug-Induced Disorders of Bone MetabolismDrug Safety, 1994
- Overview of Recent Clinical Pharmacokinetic Studies with Acitretin (Ro 10-1670, Etretin)Dermatology, 1989
- Histomorphometric analysis of a calcaneal stress fracture: A possible complication of fluoride therapy for osteoporosisBone, 1986
- Steroid-Induced Fractures and Bone Loss in Patients with AsthmaNew England Journal of Medicine, 1983
- Bone loss in adults receiving alternate day glucocorticoid therapyArthritis & Rheumatism, 1981